{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-009272","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2022-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.109331+00:00","generated_at":"2026-06-26T09:16:04.927001+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Microbot Medical appoints Rachel Vaknin as CFO, replacing David Ben Naim effective April 1, 2022","bullets":["David Ben Naim resigned as CFO effective April 1, 2022; Rachel Vaknin appointed as successor.","Vaknin joined as VP Finance in Jan 2022; previously CFO at Imagry and FP&A manager at Mellanox.","Vaknin receives base salary NIS32,000/mo + NIS8,000 global comp, annual bonus up to 20% of salary, and options for 20,000 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-009272","json":"https://secwatch.observer/filing/0001493152-22-009272.json","markdown":"https://secwatch.observer/filing/0001493152-22-009272.md","text":"https://secwatch.observer/filing/0001493152-22-009272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:16:04.927001+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6495ce4425","claim":"Rachel Vaknin was appointed as Chief Financial Officer at Microbot Medical Inc..","evidence_excerpt":"As of April 1, 2022, the Company appointed Rachel Vaknin, age 43, as its Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"c24af12571","claim":"David Ben Naim resigned as Chief Financial Officer at Microbot Medical Inc..","evidence_excerpt":"As of April 1, 2022, David Ben Naim, the Chief Financial Officer of Microbot Medical Inc. (the “Company”), resigned from his position with the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}